Letter: Khorana's Achievement

In describing the "Origins of DNA Synthesis" (The Scientist, March 19, 1990, page 30), Carole F. Gan writes: "In 1968, Har Goribind [sic] Khorana and his colleagues at the University of Wisconsin, Madison, were the first to succeed in chemically synthesizing a polynucleotide, the transfer RNA (tRNA) for alanine. Although this was indeed a historic achievement - one that won Khorana the Nobel Prize in Physiology and Medicine - there were no known biological applications for the technique at the

Written byJanardan Pandey
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In describing the "Origins of DNA Synthesis" (The Scientist, March 19, 1990, page 30), Carole F. Gan writes: "In 1968, Har Goribind [sic] Khorana and his colleagues at the University of Wisconsin, Madison, were the first to succeed in chemically synthesizing a polynucleotide, the transfer RNA (tRNA) for alanine. Although this was indeed a historic achievement - one that won Khorana the Nobel Prize in Physiology and Medicine - there were no known biological applications for the technique at the time."

I would like to correct two items in this description. First, Har Gobind Khorana synthesized the DNA coding for the alanine tRNA. Second, although, as Gan states, this was a historic achievement, this is not the accomplishment for which Khorana was awarded the Nobel Prize. He received the Nobel Prize for his work on the genetic code before he synthesized the gene for alanine tRNA.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies